Figure 5. Time-dependent changes in systolic blood pressure (SBP) (A) and proteinuria (B) before and after reducing salt intake, and effects of tempol (0–4 weeks; HS + tempol-NS) and eplerenone (4–8 weeks; HS-HS + eplerenone) treatment.

Data are expressed as means ± S.E.M.; n = 10 per group. *P<0.05, **P<0.01, compared to high salt (HS)-normal salt (NS) group.